Scinai Immunotherapeutics (SCNI) EBIT Growth (5y) (2019 - 2026)
Scinai Immunotherapeutics (SCNI) EBIT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02% |
| Mar 31, 2025 | 39.93% |
| Sep 30, 2024 | 33.72% |
| Jun 30, 2024 | -74.27% |
| Mar 31, 2024 | 17.81% |
| Dec 31, 2023 | 50.85% |
| Sep 30, 2023 | -4.58% |
| Jun 30, 2023 | 18.27% |
| Mar 31, 2023 | 23.62% |
| Dec 31, 2022 | 6.08% |
| Mar 31, 2022 | -26.20% |
| Mar 31, 2021 | -21.89% |
| Dec 31, 2020 | -31.73% |
| Sep 30, 2020 | 93.50% |
| Mar 31, 2020 | -61.55% |
| Sep 30, 2019 | -57.38% |
| Mar 31, 2019 | -28.82% |